|
(11) | EP 1 503 752 A1 |
(12) |
|
|
|
|
|||||||||||||||||||
(54) | USE OF 8-PRENYLFLAVANONES FOR ANTI-ANGIOGENESIS THERAPY AND FOR FIBRINOLYTIC THERAPY |